BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6243416)

  • 1. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon treatment inhibits glycosylation of a viral protein.
    Maheshwari RK; Banerjee DK; Waechter CJ; Olden K; Friedman RM
    Nature; 1980 Oct; 287(5781):454-6. PubMed ID: 6159539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of interferon on glycoprotein and membrane protein of vesicular stomatitis virus released from murine and simian cells.
    Drebot MA; Lee SH; Rozee KR
    J Interferon Res; 1984; 4(2):167-72. PubMed ID: 6205101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pseudorabies virus replication by vesicular stomatitis virus. II Activity of defective interfering particles.
    Dubovi EJ; Youngner JS
    J Virol; 1976 May; 18(2):534-41. PubMed ID: 178895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity.
    Maheshwari RK; Friedman RM
    Virology; 1980 Mar; 101(2):399-407. PubMed ID: 6244697
    [No Abstract]   [Full Text] [Related]  

  • 8. Low infectivity of vesicular stomatitis virus (VSV) particles released from interferon-treated cells is related to glycoprotein deficiency.
    Maheshwari RK; Husain MM; Friedman RM
    Biochem Biophys Res Commun; 1983 Nov; 117(1):161-8. PubMed ID: 6318745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
    Pattnaik AK; Wertz GW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1379-83. PubMed ID: 1847519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses.
    Friedman RM; Costa JC; Ramseur JM; Meyers MW; Jay FT; Chang EH
    J Infect Dis; 1976 Jun; 133 Suppl():A43-50. PubMed ID: 180209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell killing by viruses. III. The interferon system and inhibition of cell killing by vesicular stomatitis virus.
    Marcus PI; Sekellick MJ
    Virology; 1976 Feb; 69(2):378-93. PubMed ID: 176779
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon induces the production of membrane protein-deficient and infectivity-defective vesicular stomatitis virions through interference in the virion assembly process.
    Jay FT; Dawood MR; Friedman RM
    J Gen Virol; 1983 Mar; 64 Pt 3():707-12. PubMed ID: 6186764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
    Youngner JS; Thacore HR; Kelly ME
    J Virol; 1972 Aug; 10(2):171-8. PubMed ID: 4342236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human gamma-interferon. II. Effect on viral macromolecular synthesis.
    Ulker N; Samuel CE
    J Biol Chem; 1985 Apr; 260(7):4324-30. PubMed ID: 2984202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon induced inhibition of enveloped viruses.
    Maheshwari RK; Friedman RM
    Prog Clin Biol Res; 1985; 202():297-305. PubMed ID: 2421308
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and distribution of vesicular stomatitis virus-specific polypeptides in the absence of progeny production.
    Little SP; Huang AS
    Virology; 1977 Aug; 81(1):37-47. PubMed ID: 196401
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of RNA and protein synthesis in interferon-treated HeLa cells infected with vesicular stomatitis virus.
    Simili M; de Ferra F; Baglioni C
    J Gen Virol; 1980 Apr; 47(2):373-84. PubMed ID: 6154130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of interferon inhibition of viruses that bud from the plasma membrane.
    Friedman RM; Maheshwari RK; Jay FT; Czarniecki C
    Ann N Y Acad Sci; 1980; 350():533-44. PubMed ID: 6165302
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of L cells persistently infected with VSV: factors involved in the regulation of persistent infection.
    Nishiyama Y
    J Gen Virol; 1977 May; 35(2):265-79. PubMed ID: 195007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective isolation of mutants of vesicular stomatitis virus defective in production of the viral glycoprotein.
    Lodish HF; Weiss RA
    J Virol; 1979 Apr; 30(1):177-89. PubMed ID: 225514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.